These are the winners and losers in Norway’s cancer drug tender

CHMP recommends 12 medicines at September meeting

Enhertu becomes available in the UK for HER2-low advanced breast cancer

University of Oslo aims for first Norwegian opportunity cost estimate in 2027

Medicinrådet issues two green lights and two red lights

The Danish Medicines Council launches new company application portal

New overview simplifies type 2 diabetes treatment guidance in Denmark

Denmark invites stakeholders to EU HTA dialogue meeting

DMP updates STA submission guidance

Updates on the use of AI in healthcare and digital health and care in the EU